CClinicalTrials.gg
CompletedNCT06048497Updated Sep 28, 2023

The Role of Carotid Flow Time-Based Fluid Administration in Caesarean Section

An observational study in Spinal Anesthesia and Cesarean Section, sponsored by Cukurova University. Completed at 2 sites in Turkey. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-09-28.

Sponsored by Cukurova University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
72
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

It has been reported that corrected carotid flow time (FTc) may indicate the responsiveness of spontaneously breathing patients to fluid therapy. The primary objective of the study is to determine the effect of fluid preload applied to patients with preanesthetic FTc values below the cut-off value on the incidence of hypotension in cesarean section (C/S) surgery. Pregnant women who underwent cesarean section under spinal anesthesia were included in this prospective study. In the preoperative care unit, patients were assigned to two groups according to their baseline FTc values. Patients with baseline FTc \< 327 ms were assigned to the first group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc > 327 ms. On the other hand, patients with baseline FTc > 327 ms were assigned to the second group, and preload fluid was not administered to these patients. Intraoperative hemodynamic data were recorded for each patient.

02

Conditions studied

  • Spinal Anesthesia
  • Cesarean Section

Browse trials for

Keywords

  • Cesarean section
  • Carotid flow time
  • Preload fluid
  • Hypotension
  • Spinal anesthesia
03

In context

Hypotension

1,003 studies on the registry are indexed under Hypotension; 173 are open to participants now.

This study's enrollment of 72 is below the median of 84 across 294 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Cukurova University is the lead sponsor of 247 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

ASA II pregnant women between the ages of 20 and 40 who were undergoing elective cesarean section, and had uncomplicated singleton term pregnancies, and agreed to participate in the study were included.

Inclusion criteria

  • 20-40 years of age pregnant women
  • American Society of Anesthesiologists (ASA) physical status-II patients
  • Uncomplicated, singleton, term pregnancy
  • Elective C/S surgery

Exclusion criteria

Exclusion Criteria:

  • Placental disorders
  • Gestational hypertensive disorders
  • Morbid obesity (BMI>39 kg/m2)
  • Carotid stenosis more than 50%
  • Baseline SAP more than 160 mmHg
  • Arrhythmia
  • History of cardiovascular or cerebrovascular disease, and chronic kidney disease (estimated glomerular filtration rate \<60 mL/min/1.73 m2)
  • Emergency surgery
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
72 participants (actual)
Patient registry
No

Groups and cohorts

  • Preload

    Patients with baseline FTc \< 327 ms were assigned to the preload group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc \> 327 ms.

    Device: Corrected carotid flow time measurement guided fluid preload

  • Non-preload

    Patients with baseline FTc \> 327 ms were assigned to the non-preload group, and preload fluid was not administered to these patients

Interventions

  • DeviceCorrected carotid flow time measurement guided fluid preload

    Preoperative FTcs of pregnant women who underwent C/S operation were measured, and those below the cut-off value (327 ms) determined in previous studies were preloaded with Ringer Lactate until FTc was \> 327 ms.

06

What researchers measure

Primary outcomes

  1. The incidence of intra-operative hypotension

    Hypotension definitions included systolic arterial pressure (SAP) below 80 mmHg, or mean arterial pressure (MAP) below 65 mmHg, or a decrease in SAP of more than 30% below baseline, or a decrease in MAP of more than 20% below baseline, or any combination of all these definitions.

    Time frame: During surgery

07

Study locations

2 sites
  • Cukurova University
    Adana, Saricam 01330, Turkey
  • Çukurova University; Faculty of Medicine
    Adana, Sarıçam 01330, Turkey
08

References and documents

Individual participant data

Plan to share: No — All data were anonymized by the local researcher. Therefore, data collection was pseudonymous and the patient's name did not appear on any case report form or other study document. All collected data were kept confidential. This study was conducted in accordance with the revision of the Declaration of Helsinki (2008). International Conference on Harmonisation-Good Clinical Practice (ICH-GCP) was strictly adhered to.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06048497
Lead sponsor
Cukurova University
Responsible party
Demet Laflı Tunay (Principal Investigator, Cukurova University) — Principal investigator
First posted
Sep 21, 2023
Start date
Nov 15, 2022
Primary completion
May 20, 2023
Completion
Jul 5, 2023
Last update
Sep 28, 2023

Study contacts

Demet Laflı Tunay, Dr.
principal investigator · Çukurova University, Balcalı Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion